INTERNATIONAL PATENT: GENZYME CORPORATION, FARENC, CHRISTINE, TEUTONICO, DONATO, SCHNYDER, SABINE FILES APPLICATION FOR "ECLITASERTIB FOR TREATING RECEPTOR-INTERACTING PROTEIN KINASE 1 -MEDIATED DISEASES"

GENEVA, Jan. 7 -- GENZYME CORPORATION (450 Water StreetCambridge, Massachusetts 02141), FARENC, Christine (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), TEUTONICO, Donato (c/o Sanofi, Patent Department450 Water Street02141 Cambridge), SCHNYDER, Sabine (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141) filed a patent application (PCT/US2025/035480) for "ECLITASERTIB FOR TREATING RECEPTOR-INTERACTING PROTEIN KINASE 1 -MEDIATED DISEASES" on Jun 26, 2025. With publication no. WO/2026/006589, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is manag...